Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (106K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Jankowsky, E.
Right arrow Articles by Schwenzer, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jankowsky, E.
Right arrow Articles by Schwenzer, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 Oxford University Press 2690-2693

Peptide nucleic acid (PNA) is capable of enhancing hammerhead ribozyme activity with long but not with short RNA substrates

Peptide nucleic acid (PNA) is capable of enhancing hammerhead ribozyme activity with long but not with short RNA substrates Eckhard Jankowsky+, Günther Strunk1 and Bernd Schwenzer*

Institut für Biochemie, Technische Universität Dresden, Mommsenstraße 13, 01069 Dresden, Germany and 1Abteilung Biochemische Kinetik, Max-Planck-Institut für Biophysikalische Chemie, Am Faßberg, 37018 Göttingen, Germany

Received May 9, 1997; Revised and Accepted May 30, 1997

ABSTRACT

Long RNA substrates are inefficiently cleaved by hammerhead ribozymes in trans. Oligonucleotide facilitators capable of affecting the ribozyme activity by interacting with the substrates at the termini of the ribozyme provide a possibility to improve ribozyme mediated cleavage of long RNA substrates. We have examined the effect of PNA as facilitator in vitro in order to test if even artificial compounds have facilitating potential. Effects of 12mer PNA- (peptide nucleic acid), RNA- and DNA-facilitators of identical sequence were measured with three substrates containing either 942, 452 or 39 nucleotides. The PNA facilitator enhances the ribozyme activity with both, the 942mer and the 452mer substrate to a slightly smaller extent than RNA and DNA facilitators. This effect was observed up to PNA facilitator:substrate ratios of 200:1. The enhancement becomes smaller as the PNA facilitator:substrate ratio exceeds 200:1. With the 39mer substrate, the PNA facilitator decreases the ribozyme activity by more than 100-fold, even at PNA facilitator:substrate ratios of 1:1. Although with long substrates the effect of the PNA facilitator is slightly smaller than the effect of identical RNA or DNA facilitators, PNA may be a more practical choice for potential applications in vivo because PNA is much more resistant to degradation by cellular enzymes.

INTRODUCTION

Hammerhead ribozymes are catalytic RNA molecules capable of cleaving RNA substrates in trans (1 ,2 ). By choosing target complementary stems flanking the catalytic hammerhead motif, ribozyme activity can be directed against almost any RNA and may thereby be useful for therapeutical purposes (3 -5 ).

Usually the intention is to inactivate RNAs containing several hundred nucleotides (nt). However, compared with substrates of 20-60 nt in length, ribozyme activity decreases as the length of the substrates increases (6 ). For potential therapeutical applications it is essential that hammerhead ribozymes are able to cleave long RNAs as well. Therefore, it is important to explore possibilities of enhancing hammerhead activity to cleave long RNAs (7 ).

Besides the improvement of ribozyme activity through the addition of proteins (8 ,9 ), oligonucleotides capable of interacting with the substrate at the termini of the ribozyme, so called oligo- nucleotide facilitators (10 ,11 ), were found to enhance hammerhead activity with long RNAs (12 ).

RNA- as well as DNA-facilitators have the potential to pre-form potentially structured substrates for ribozyme attack (13 ,14 ). Since higher order structures are considered to be the main hindrance for efficient ribozyme-mediated cleavage of long RNAs (6 ,15 ), it is pertinent to examine further possibilities in order to force structural changes of the substrates such that hammerhead activity is enhanced.

For this purpose peptide nucleic acid (PNA) oligonucleotides are promising. PNA is capable of binding with nucleic acids by Watson-Crick base pairing (16 ,17 ). The stability of PNA-RNA hybrids is considerably less sensitive to cation concentration than the hybrid stability of natural nucleic acids and PNA-RNA hybrids are usually more stable then RNA-RNA or RNA-DNA hybrids, respectively (17 ). Moreover, homopyrimidine PNA is able to bind with double stranded nucleic acids by a strand displacement mechanism (18 ,19 ). With a view to a potential application in cellular systems, of primary interest is the resistance of PNA to both cellular nucleases and proteases (20 ).

Attracted by these potentially favorable properties of PNA, we examined in vitro the effect of a PNA facilitator on the hammerhead ribozyme activity with substrates of different length.

MATERIALS AND METHODS

RNA/DNA synthesis and labelling

The ribozyme, short substrates (39mer), RNA- and DNA-facilitators were chemically synthesized and purified as described (14 ,21 ). Long substrates (942mer and 452mer) were synthesized by T7 in vitro transcription from PCR-generated templates (14 ). 39mer substrates were 5'-labelled with [[gamma]-32P]ATP, long substrates were internally labelled during transcription (14 ).

PNA synthesis

The 12mer PNA (H-TGA AGG GTT TGG-NH2) was synthesized by solid phase t-Boc chemistry as described by Nielsen et al. (16 ) using an automated PNA-synthesizer (PerSeptive Biosystems). The crude product of a 1 [mu]mol setup was purified by reversed phase HPLC on a Ultrasphere ODS C-18, 4.6 * 250 mm column (Beckman) using an acetonitrile/TFA gradient (from A to B linear in 30 min: A, water/0.1% TFA; B, acetonitrile/0.1% TFA).

Ribozyme reactions

Ribozyme reactions were performed at 37oC in 10-20 [mu]l 50 mM Tris-HCl (pH 7.5) with 10 mM MgCl2 as described (14 ). Aliquots were taken at appropriate times and quenched by addition of 8 [mu]l ice cold stop buffer (8 M urea, 50 mM EDTA, 7.5% glycerine, 0.05% bromophenol blue and 0.05% xylene cyano blue). Products were separated from uncleaved substrate by either 4% denaturing PAGE (long substrates) or 20% denaturing PAGE (39mer substrates). Gels were analyzed by radioanalytic scanning.

RESULTS

The hammerhead substrates (Fig. 1 A) represent domains of the processed human tissue factor mRNA (22 ). The ribozyme was constructed with 7 nt in every stem in order to ensure the combination of sufficient catalytic activity and high substrate specificity (23 ,24 ). 12mer oligonucleotide facilitators which complement the substrat adjacent to the 3'-end of the ribozyme were recently proved to be efficient for enhancing the hammerhead activity with the long substrates (14 ).


Figure 1.Sequences of substrates, facilitators and ribozyme. (A) The substrates S 942 and S 452 are named after the number of nucleotides they contain. Both substrates have an identical 5'-terminus and differ in their 3'-terminus. S 39 is a smaller segment of the long substrates. (B) In the substrate S 39 IFB the facilitator binding sequences are inverted. Thus, the facilitator capable of binding 3'-end to the ribozyme with S 39 binds 5'-end to the ribozyme with S 39 IFB. All facilitators contain identical sequences. PNA facilitators: NH2 indicates the carboxamide group at the C-terminus; H indicates the amino group at the N-terminus. (C) Chemical structure of PNA with a carboxamide group at the C-terminus.

At the conditions used, the limiting step of the ribozyme reaction with the long substrates is ribozyme-substrate association (14 ). The rate of product formation reflects the ribozyme-substrate association and is therefore quantitatively described by the ribozyme-substrate association rate constant k1. This rate constant was calculated by fitting the time course of product formation into the integrated second order reaction rate law (14 ).

The PNA facilitator enhances the ribozyme-substrate association rate constant by 8-fold with S 452 and by 35-fold with S 942 (Table 1 ). This enhancement is slightly lower, although of the same order of magnitude, than the activation by the RNA and the DNA facilitators, which cause a 12-fold increase with S 452 and an ~50-fold increase with S 942 (Table 1 ).

Table 1 Facilitator effect on the hammerhead ribozyme activity with the long substrates
Type of S 452 S 942
facilitator k1a (105 min-1M-1) k1b relative k1a (105 min-1M-1) k1b relative
no facilitator 0.94 +- 0.06 1 0.11 +- 0.01c 1
RNA facilitator 11.3 +- 1.0 12 6.2 +- 0.4 56
DNA facilitator 11.7 +- 1.2 12 5.8 +- 0.4 53
PNA facilitator 7.5 +- 0.7 8 3.8 +- 0.6 35
aThe ribozyme substrate association rate constant k1 describes the activity of the hammerhead ribozyme, since the ribozyme substrate association is rate limiting under the conditions used (14). k1 was estimated by non-linear regression of the time course of product formation with the integrated second order reaction rate law. Every time course consists of five points and was measured 3-5-fold. The errors represent the standard deviations resulting from the calculation of the average value of the different estimations. The standard deviations of the non-linear regressions were between 0.03 and 0.12. Concentrations unless otherwise stated: substrate, 30 nM; facilitators, 3 [mu]M; ribozyme, 100 nM.
bk1 relative represents the quotient of k1 with facilitator divided by k1 without facilitator.
cEstimated with: substrate, 60 nM; facilitators, 3 [mu]M; ribozyme, 200 nM.

However, the PNA facilitator-mediated effect was found to be strongly dependent on the PNA-substrate ratio (Fig. 2 ). The maximal enhancement with the PNA facilitators is achieved at a facilitator:substrate ratio of 10:1, which is similar to the value obtained with RNA and DNA facilitators. At higher facilitator: substrate ratios, the effect with RNA and DNA facilitators remains at the value obtained at a 10-fold facilitator excess. In contrast, the activity-enhancement with the PNA facilitator decreases as the PNA excess becomes >200-fold (Fig. 2 ). No ribozyme activity could be detected at PNA facilitator:substrate ratios of 1000 (Fig. 2 ).


Figure 2. Effect of the PNA:substrate ratio on the ribozyme activity with the long substrates. The PNA:substrate ratios are indicated under the gels. The ordinates of the diagrams represent the effects of the PNA:substrate ratio on the observed ribozyme-substrate association rate constant k1 and indicates the quotient of k1 with facilitator divided by k1 without facilitator (Table 1). Please note the logarithmic scale of the abscissa. Triangles, RNA facilitator; circles, PNA facilitator. Reaction time, 15 min. Concentrations: substrate, 30 nM; ribozyme, 100 nM.

With the 39mer substrate the PNA facilitator inhibited the ribozyme activity even at a facilitator:substrate ratio of 1:1 (Fig. 3 A and B). After a reaction time of 10 min no significant product formation could be observed with the PNA facilitator (Fig. 3 B and C). Thus, a >100-fold inhibition of the ribozyme activity was caused by the PNA facilitator. The inhibiting effect was independent on the facilitator binding site, as this inhibition was also observed with a substrate where the facilitator binding sequences were switched (Fig. 3 C). This behaviour was different from the effects observed with RNA and DNA facilitators which enhance the hammerhead activity at facilitator:substrate ratios of >= 100 (21 ).


Figure 3. Effect of the PNA facilitator on the hammerhead activity with the 39mer substrates. (A) Formation of the complex PNA-S 39, followed by gel-shift analysis with a 15% native polyacrylamide gel, containing 10 mM MgCl2. Substrate concentrations, 30 nM. Lane 1, S 39 without facilitator; lane 2, S 39/PNA 5:1; lane 3, S 39/PNA 2:1; lane 4, S 39/PNA 1:1; lane 5, S 39/RNA facilitator 1:1. (B) Reaction with incomplete S 39-PNA complex formation as followed by denaturing gel electrophoresis. Reaction times in minutes are indicated under the gel. Concentrations: S 39, 30 nM; ribozyme, 100 nM. (C) Inhibition of the ribozyme reaction at PNA excess with both S 39 and S 39 IFB, followed by denaturing PAGE. Reaction times, 10 min. Lane 1: S 39 30 nM without PNA and ribozyme; lane 2, S 39 30 nM + ribozyme 100 nM; lane 3, S 39 IFB 30 nM + ribozyme 100 nM; lane 4, PNA 30 nM + S 39 30 nM + ribozyme 100 nM; lane 5: PNA 60 nM + S 39 30 nM + ribozyme 100 nM; lane 6, PNA 150 nM + S 39 30 nM + ribozyme 100 nM; lane 7, PNA 300 nM + S 39 30 nM + ribozyme 100 nM; lane 8, PNA 30 nM + S 39 IFB 30 nM + ribozyme 100 nM; lane 9, PNA 60 nM + S 39 IFB 30 nM + ribozyme 100 nM; lane 10, PNA 150 nM + S 39 IFB 30 nM + ribozyme 100 nM; lane 11, PNA 300 nM + S 39 IFB 30 nM + ribozyme 100 nM; lane 12, PNA 600 nM + S 39 IFB 30 nM + ribozyme 100 nM; lane 13, S 39 IFB without PNA and ribozyme.

In order to examine whether the PNA facilitator-mediated inhibition was caused by binding of the PNA to the ribozyme, the PNA:substrate ratios were varied such that the substrate was in excess over the PNA (Fig. 3 B). Thus, only a fraction of substrate was trapped by association with the PNA. The kinetic analysis of the fraction of the product formed from the remaining `free' substrate yielded the same rate constants as resulted from reactions without facilitator (Fig. 3 B).

An inhibition was also caused by the PNA facilitator in reactions with preannealing of ribozyme and S 39 (not shown).

DISCUSSION

PNA facilitators affect the ribozyme activity with all substrates tested. While with long substrates an enhancement was observed in the same order of magnitude as the enhancement caused by RNA and DNA facilitators, the ribozyme activity was strongly inhibited with a short substrate as the PNA-substrate complex was formed to full extent.

With the long substrates, a 10-fold excess of PNA facilitator is necessary to achieve the maximal enhancement at the concentrations used. This is very similar to the excess of RNA and DNA facilitator required for their maximal enhancement. Since the dependence of the facilitator effect on the facilitator:substrate ratio is determined by the stability of the facilitator-substrate complex (14 ), it is evident that under the reaction conditions the PNA-long-substrate complexes are of similar stability as the complexes formed between DNA/RNA facilitators and these substrates. Thus, in our system, PNA is not more efficient than an RNA or a DNA facilitator in pre-forming long RNA substrates for ribozyme attack.

The inhibition of the hammerhead activity by higher PNA substrate ratios might be a result of multiple binding of PNA to the substrate.

The unexpected inhibition of the hammerhead activity with the 39mer substrates should be the result of an influence of the cleavage step, which is suggested by the inhibition of both reactions with and without ribozyme-substrate preannealing. The inhibiting effect is also independent of whether the PNA facilitator binds 3'-end or 5'-end to the ribozyme (Fig. 3 C). Non-specific binding of the PNA to the ribozyme could be ruled out, since the reactions were performed under single turnover conditions, i.e., with an excess of ribozyme over the substrate. Under these conditions, direct binding of the PNA to the ribozyme have resulted in a `trapping' of a fraction of ribozyme and the reduction of the activity would have been considerably smaller than actually observed.

Most likely, formation of multimeric PNAn-RNA aggregates causes the inhibition at the conditions used. Since no more than two bands on native PAGE appeared (Fig. 3 A), these interactions should be weak. Because the ribozyme's catalytic core has inherent flexibility (25 ,26 ), the ribozyme-substrate complex might be trapped in less active conformations forced by these aggregations.

Although, in our system, the effect of a PNA facilitator is not higher than the effect of a DNA or RNA facilitator, PNA is useful for enhancing the activity of a hammerhead ribozyme to cleave long RNA substrates. Due to the resistance of PNA against nucleases and proteases this result is of interest especially for a potential in vivo application.

ACKNOWLEDGEMENTS

We thank Dr Anna Marie Pyle and Justin B. Green for helpful comments on the manuscript. We are grateful to the researchers at the Institute of Physiological Chemistry of the Dresden University for the opportunity to make use of their laboratory facilities. Our work was supported by a grant from the DFG (Schw638/1-1).

REFERENCES

1 Uhlenbeck, O.C. (1987) Nature 328, 596-600. MEDLINE Abstract

2 Symons, R.H. (1992) Annu. Rev. Biochem. 61, 614-671.

3 Haseloff, J. and Gerlach, W. (1988) Nature 334, 585-591. MEDLINE Abstract

4 Sarver, N., Cantin, E.M., Chang, P.S., Zaia, J.A., Ladne, P.A., Stephens, D.A. and Rossi, J.J. (1990) Science 247, 1222-1224. MEDLINE Abstract

5 Marschall, P., Thomson, J.B. and Eckstein, F. (1994) Cell. Mol. Neurobiol. 14, 523-537. MEDLINE Abstract

6 Heidenreich, O. and Eckstein, F. (1992) J. Biol. Chem. 267, 1904-1909. MEDLINE Abstract

7 Rossi, J.J. (1993) Methods 5, 1-5.

8 Müller, G., Strack, B., Danull, J., Sproat, B.S., Surovoy, A., Jung, G. and Moelling, K. (1994) J. Mol. Biol. 242, 422-429. MEDLINE Abstract

9 Mahieu, M., Hendrix, C., Ooms, J., Herdewijn, P. and Content, J. (1995) Biochem. Biophys. Res. Commun. 214, 36-43. MEDLINE Abstract

10 Goodchild, J. (1992) Nucleic Acids Res. 20, 4607-4612. MEDLINE Abstract

11 Perkins, T.A., Wolf, D.E. and Goodchild, J. (1996) Biochemistry 35, 16370-16377. MEDLINE Abstract

12 Denman, R. (1993) Nucleic Acids Res. 21, 4119-4125. MEDLINE Abstract

13 Denman, R. (1996) FEBS Lett. 382, 116-121. MEDLINE Abstract

14 Jankowsky, E. and Schwenzer, B. (1996) Biochemistry 35, 15313-15321. MEDLINE Abstract

15 Scarabino, D. and Tocchini-Valentini, G.P. (1996) FEBS Lett. 383, 185-190. MEDLINE Abstract

16 Nielsen, P.E., Egholm, M., Berg, R.H. and Buchardt, O. (1991) Science 214, 1497-1500.

17 Egholm, M., Buchhardt, O., Christensen, L., Behrens, C., Freier, S.M., Driver, D.A., Berg, R.H., Kim, S.K., Nordén, B. and Nielsen, P.E. (1993) Nature 365, 566-568. MEDLINE Abstract

18 Demidov, V.V., Yanilovich, M.V., Belotserkovskii, B.P., Frank-Kamenetskii, M.D. and Nielsen, P.E. (1995) Proc. Natl. Acad. Sci. USA 92, 2637-2641. MEDLINE Abstract

19 Wittung, P., Nielsen, P. and Nordén, B. (1996) J. Am. Chem. Soc. 118, 7049-7054.

20 Knudsen, H. and Nielsen, P.E. (1996) Nucleic Acids Res. 24, 494-500. MEDLINE Abstract

21 Jankowsky, E. and Schwenzer, B. (1996) Nucleic Acids Res. 24, 423-429. MEDLINE Abstract

22 Scarpati, E.M., Duanzhi, W., Broze, G.J., Miletich, J.P., Flandermeyer, R.R., Siegel, N.R. and Sadler, J.E. (1987) Biochemistry 26, 5234-5238. MEDLINE Abstract

23 Herschlag, D. (1991) Proc. Natl. Acad. Sci. USA 88, 6921-6925. MEDLINE Abstract

24 Bertrand, E., Pictet, R. and Grange, T. (1994) Nucleic Acids Res. 22, 293-300. MEDLINE Abstract

25 Woisard, A., Fourrey, J.L. and Favre, A. (1994) J. Mol. Biol. 239, 366-370. MEDLINE Abstract

26 Herschlag, D., Khosla, M., Tsuchihashi, Z. and Karpel, R.L. (1994) EMBO J. 13, 2913-2924. MEDLINE Abstract


*To whom correspondence should be addressed. Tel: +49 351 463 6447; Fax: +49 351 463 5506; Email: bernd.schwenzer@chemie.tu-dresden.de

+Present address: Department of Biochemistry and Molecular Biophysics, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Print PDF (106K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Jankowsky, E.
Right arrow Articles by Schwenzer, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jankowsky, E.
Right arrow Articles by Schwenzer, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?